Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Fucidin in patients on haemodialysis
View through CrossRef
Fucidin is useful against `antibiotic-resistant staphylococci' which are a major problem in causing shunt site infections in patients on chronic intermittent haemodialysis for end-stage renal failure. A new form of intravenous fucidin has been usedin vivoin three patients on haemodialysis, and also in experimentsin vitroin order to assess its dialysing properties. The experimentsin vitroshow that some fucidin does cross the dialyser membrane but, in the patients studied, adequate serum levels were maintained throughout a 10-hour haemodialysis. A single intravenous dose of Fucidin is, therefore, adequate for treating `antibiotic-resistant' staphylococcal infections in patients during haemodialysis.
Title: Fucidin in patients on haemodialysis
Description:
Fucidin is useful against `antibiotic-resistant staphylococci' which are a major problem in causing shunt site infections in patients on chronic intermittent haemodialysis for end-stage renal failure.
A new form of intravenous fucidin has been usedin vivoin three patients on haemodialysis, and also in experimentsin vitroin order to assess its dialysing properties.
The experimentsin vitroshow that some fucidin does cross the dialyser membrane but, in the patients studied, adequate serum levels were maintained throughout a 10-hour haemodialysis.
A single intravenous dose of Fucidin is, therefore, adequate for treating `antibiotic-resistant' staphylococcal infections in patients during haemodialysis.
Related Results
MO916THE EFFECT OF EXTENDED HAEMODIALYSIS ON NUTRITIONAL PARAMETERS: A SYSTEMATIC REVIEW
MO916THE EFFECT OF EXTENDED HAEMODIALYSIS ON NUTRITIONAL PARAMETERS: A SYSTEMATIC REVIEW
Abstract
Background and Aims
Individuals who receive haemodialysis have a high mortality rate, up to 20% within one year of star...
Acute haemodynamic changes during haemodialysis do not exacerbate gut hyperpermeability
Acute haemodynamic changes during haemodialysis do not exacerbate gut hyperpermeability
Abstract
Introduction: The gastrointestinal tract is a potential source of inflammation in dialysis patients. In vitro studies suggest breakdown of the gut barrier i...
Explaining Indonesian Patients’ Experiences About Changes in the Hemodialysis Cost System
Explaining Indonesian Patients’ Experiences About Changes in the Hemodialysis Cost System
Aim: To explore the experience of haemodialysis patients in Indonesia over a decade, amidst changes in the cost system in hospitals. Since its implementation, the Universal Health ...
MO722: Cardiac Biomarkers (NT-proBNP, Troponin I) and Heart Failure in Haemodialysis Patients
MO722: Cardiac Biomarkers (NT-proBNP, Troponin I) and Heart Failure in Haemodialysis Patients
Abstract
BACKGROUND AND AIMS
Patients with chronic kidney disease (CKD) stage 5 on haemodialysis are at a high risk of cardiovas...
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort
ABSTRACTBackgroundLymphocyte ratios reflect inflammation and have been associated with adverse outcomes in a range of diseases. We sought to determine any association between neutr...
THE ANTICOAGULANT THERAPY OF HAEMODIALYSIS PATIENTS WITH ACUTE CORONARY SYNDROME
THE ANTICOAGULANT THERAPY OF HAEMODIALYSIS PATIENTS WITH ACUTE CORONARY SYNDROME
Objectives
To evaluate the effect of different dose of anticoagulants in haemodialysis patients with acute coronary syndrome (not including ST-elevate myocardial ...
QUALITY OF LIFE AMONG PATIENTS UNDERGOING HAEMODIALYSIS IN JAKARTA, INDONESIA
QUALITY OF LIFE AMONG PATIENTS UNDERGOING HAEMODIALYSIS IN JAKARTA, INDONESIA
Haemodialysis is a continuous treatment provided to patients with chronic kidney disease as a replacement for renal function. It is important to assess the quality of life among th...
Assessment of implementation of the Pradhan Mantri national dialysis Programme in Hospitals in Delhi
Assessment of implementation of the Pradhan Mantri national dialysis Programme in Hospitals in Delhi
Background: Annual-demand for haemodialysis-sessions in India is 3.4 Crores. To make Renal-care-services affordable to APL and free to BPL, Ministry of Health and Family Welfare la...